GCBDD history

Therefore, it should be encouraged that you conduct your own research before making any CBD-based purchase. For example, in the UK, the use of CBD is legal, but products need to contain 0.2% THC or less, according to the Misuse of Drugs Act 1971.

With the bill passed in New Mexico, and the decriminalization of cannabis in Oregon in 1973, more states began to legalize the use of marijuana as a medication.

As research advanced, a landmark victory occurred, when New Mexico passed the 1978 Controlled Substances Therapeutic Research Act, a bill which legally recognized the medicinal value of cannabis.

But the history of CBD took another big leap forward when the first cannabinoid receptor was discovered in a mouse in 1988 by Americans Allyn Howlett and William Devane.

After a fight lasting several decades, cannabis advocates finally made a breakthrough in 1996 with the legalization of the plant for medical use in California.

In 1997, a hemp rope from almost 29,000 years ago was discovered in the Czech Republic.

In the spring of 1998, the British government licensed a company called GW Pharmaceuticals to grow cannabis and develop a precise and consistent extract for use in clinical trials.

They recorded their research into cannabis in scrolls that date back to 2000 BCE, with CBD being referred to as shemshemet in the hieroglyphs.

Mechoulam, R., & Hanuš, L. (2002). Cannabidiol: an overview of some chemical and pharmacological aspects.

Born on the 18th of October 2006, Charlotte was a bright little girl suffering from Dravet Syndrome, a severe form of epilepsy.

Gardner about the urgent need to institute better testing, agreed to help fund a cannabis analysis lab, Steep Hill, which began its operations in 2008.

By the summer of 2009, the lab had identified five strains with significant CBD and THC. Mr.

In the fall of 2010, a Project CBD website was set up where anyone could look through studies organized by disease or condition.

Rock, E. M., Goodwin, J. M., Limebeer, C. L., Breuer, A., Pertwee, R. G., Mechoulam, R., & Parker, L. A. (2011). Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.

Perhaps the most critical turning point for CBD came in August 2013, when a CNN special hosted by Doctor Sanjay Gupta profiled a 6-year-old girl in Colorado, Charlotte Figi, who used CBD to treat her epilepsy, as well as the brawny brothers who grew her CBD, the Stanleys.

The 2014 legalization of medical CBD in Alabama, Florida, Iowa, Kentucky, Mississippi, Missouri, North Carolina, South Carolina, Tennessee, Utah, and Wisconsin represented a landmark moment in the history of the cannabinoid.

The conclusion of the 2017 report from the US National Academy of Medicine on “The Health Effects of Cannabis and Cannabinoids—The Current State of Evidence and Recommendations for Research” confirmed the limitation of scientific knowledge.

In 2018, the first CBD-based drug was approved by the FDA. The drug, Epidiolex, is used in the management of epilepsy.

By 2020, the global value of the CBD industry was estimated at $2.8 billion, and it is only getting started.

As of 2021, 18 states in the US have legalized cannabis for recreational use.